Brief: Neurocrine Biosciences Got Into Accelerated Share Repurchase Transaction To Repurchase $300 Million Of Shares Of Co's Common Stock
01/11/2024 12:55
Nov 1 (Reuters) - Neurocrine Biosciences Inc NBIX.O :
* NEUROCRINE BIOSCIENCES: GOT INTO ACCELERATED SHARE
REPURCHASE
TRANSACTION TO REPURCHASE $300 MILLION OF SHARES OF CO'S COMMON
STOCK
Source text: ID:n0000914475-24-000214
Further company coverage: NBIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall